 "Sun Pharma up over 5% as USFDA to lift import alert on Mohali facility")
Sun Pharmaceutical Industries has moved higher by 7% to Rs 729 on the National Stock Exchange (NSE) after the company said the US health regulator will lift the import alert to permit the supply of products from Mohali facility to the US market.
“Sun Pharmaceutical Industries was informed by the US Food and Drug Administration (USFDA) yesterday, that it will lift the Import Alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the Official Action Initiated (OAI) status,” the company said in a release on March 14, 2017.
This proposed action will clear the
“Sun Pharmaceutical Industries was informed by the US Food and Drug Administration (USFDA) yesterday, that it will lift the Import Alert imposed on the Mohali (Punjab) manufacturing facility and remove the facility from the Official Action Initiated (OAI) status,” the company said in a release on March 14, 2017.
This proposed action will clear the
